Cartesian Therapeutics Grants Inducement Awards to New Employees
Monday, 8 July 2024, 20:05
Cartesian Therapeutics Announces Employment Inducement Grants
Cartesian Therapeutics, a renowned mRNA cell therapy developer for autoimmune diseases, granted new employees options to purchase company stock.
- Inducement Awards: 35,198 shares offered
- Exercise Price: $24.27 per share
This action underscores the company's dedication to expanding its workforce and advancing its innovative therapies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.